scispace - formally typeset
D

Dan Chateau

Researcher at University of Manitoba

Publications -  170
Citations -  5486

Dan Chateau is an academic researcher from University of Manitoba. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 33, co-authored 145 publications receiving 4599 citations. Previous affiliations of Dan Chateau include University of California, San Diego & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.

TL;DR: Combination antibiotic therapy improves survival and clinical response of high-risk, life-threatening infections, particularly those associated with septic shock but may be detrimental to low-risk patients.
Journal ArticleDOI

Frequent Users of Emergency Departments: Developing Standard Definitions and Defining Prominent Risk Factors

TL;DR: Although substance abuse is prominent in both groups, only highly frequent users seem to visit EDs in place of other health care services, suggesting that these former patients use EDs as a main source of care.
Journal ArticleDOI

A matched cohort study of postoperative outcomes in obstructive sleep apnea: could preoperative diagnosis and treatment prevent complications?

TL;DR: Diagnosis of OSA and prescription of continuous positive airway pressure therapy were associated with a reduction in postoperative cardiovascular complications, and could be used to justify and inform large efficacy trials of perioperative continuous positiveAirway Pressure therapy in OSA patients.
Journal ArticleDOI

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

TL;DR: This study does not support the proposition of a pharmacological effect of gastric acid suppressors on the risk of HCAP and formed eight restricted cohorts of new users of NSAIDs, aged ≥40 years, using a common protocol in eight databases.